Startseite - Home

Katalog
Catalogue

eBooks

Verlage
Publishers

   Startseite :: Home
   Kontakt :: Contact
   über uns :: about us
   Datenschutz :: Privacy Policy
   Impressum
   Kundeninformation

Pancreatic Cancer

Kontakt/Bestellung
Contact/Order

via E-Mail:
info@digento.de  Contact/Order: info@digento.de

Hrsg. v. John P. Neoptolemos, Raul A. Urrutia, James Abbruzzese und Markus W. Büchler

Online, Print + Online

Print: 2010, 2 Bände, 1.390 Seiten, gebunden

Verlag :: Publisher

Springer Nature

 

Preis :: Price*

Online

399,00 EUR

Print + Online

499,00 EUR

*Der Preis versteht sich zzgl. der gesetzlich gültigen Mehrwertsteuer und Versandspesen.
Preisänderungen vorbehalten.
Price exclusive of VAT and shipping charges. Prices are subject to change.

Das Angebot richtet sich nicht an Verbraucher i. S. d. § 13 BGB und Letztverbraucher i. S. d. PAngV.

ISBN/ISSN

978-0-387-77498-5 (Online)

978-0-387-77499-2 (Print + Online)

Bestellnummer bei digento :: digento order number

106909

Verlagsinformation :: Publisher's information

Worldwide, there are an estimated 232, 000 new cases of pancreatic cancer annually. In the United States, it is the fourth leading cause of cancer death, and approximately 30,000 people die of pancreatic cancer each year. The disease is difficult to diagnose in its early stages, and most patients have incurable disease by the time they present with symptoms. The overall 5-year survival rate for this disease is less than 5%.

In organizing this handbook, Dr. Neoptolemos and his co-editors will produce a distinguished Major Reference Work devoted to pancreatic cancer. This handbook will have widespread appeal among clinicians, pathologists and basic scientists who are now struggling to understand this complex and rapidly expanding field.

Because of the recent and vast growth in both the clinical and scientific research being done in pancreatic cancer (there is currently an unprecedented investment by academia and industry in this field), each researcher's knowledge of other specialty areas outside his or her own is now often quite limited. The aim of this book is to place these the tangible advances - those that are indispensable to all working on pancreatic cancer - readily at hand. The book will focus on advances that will not become dated, and the editors will choose authors who are the very best in each area.

About this book:

- The only Major Reference Work entirely devoted to pancreatic cancer

- The contributing authors are the very best in their respective fields

- Soon to be the reference of choice among clinicians, pathologists, and basic scientists who now struggle to keep abreast of this complex and rapidly growing field

top  top